Megan A. Galle, PharmD (@meganciclovir) reviews eculizumab’s mechanism of action and its role in treating antibody mediated rejection following solid organ transplantation, discusses laboratory testing methods available for eculizumab therapeutic drug monitoring and describes the role of therapeutic drug monitoring in eculizumab treatment optimization.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
